medroxalol - CISMeF

Preferred Label : medroxalol;

MeSH note : RN given refers to parent cpd without isomeric designation;

CISMeF synonym : C20H24N2O5; a-Tocophérol; 5-[2-[[3-(1,3-benzodioxol-5-yl)-1-methylpropyl]amino]-1-hydroxyethyl]salicylamide; MDL 17330A; MDL 17331A; RMI 81968;

MeSH synonym : 5-(2-((3-(1,3-benzodioxol-5-yl)-1-methylpropyl)amino)-1-hydroxyethyl)-2-hydroxybenzamide;

MeSH CAS label : benzamide, 5-(2-((3-(1,3-benzodioxol)-5-yl)-1-methylpropyl)amino)-1-hydroxyethyl-2-hydroxy-;

MeSH Related Number : medroxalol monohydrochloride; medroxalol monohydrochloride, (R-(R*,S*))-isomer; medroxalol monohydrochloride, (S-(R*,R*))-isomer; medroxalol monohydrochloride, (S-(R*,S*))-isomer; medroxalol monohydrochloride, (R-(R*,R*))-isomer; 70161-10-3 (mono-HCl); 76959-00-7 (mono-HCl(R-(R*,R*))-isomer); 76959-01-8 (mono-HCl(S-(R*,R*))-isomer); 76959-02-9 (mono-HCl(R-(R*,S*))-isomer); 76959-03-0 (mono-HCl(S-(R*,S*))-isomer); 56290-94-9;

Registry Number MeSH : 56290-94-9;

Related CAS MeSH : 70161-10-3 (medroxalol monohydrochloride); 76959-02-9 (medroxalol monohydrochloride, (R-(R*,S*))-isomer); 76959-01-8 (medroxalol monohydrochloride, (S-(R*,R*))-isomer); 76959-03-0 (medroxalol monohydrochloride, (S-(R*,S*))-isomer); 76959-00-7 (medroxalol monohydrochloride, (R-(R*,R*))-isomer);

related registry number list (CISMeF) : 70161-10-3 (mono-HCl); 76959-00-7 (mono-HCl(R-(R*,R*))-isomer); 76959-01-8 (mono-HCl(S-(R*,R*))-isomer); 76959-02-9 (mono-HCl(R-(R*,S*))-isomer); 76959-03-0 (mono-HCl(S-(R*,S*))-isomer);

Codes EINECS : 260-099-3;

Is substance : O;

UNII : 7PX96289JA;

InChIKey : MPQWSYJGFLADEW-UHFFFAOYSA-N;

Details

Origin ID

C024892;

UMLS CUI

C0065863;

Automatic exact mappings (from CISMeF team)
- 5-[2-[[3-(1,3-benzodioxol-5-yl)-1-methylpropyl]amino]-1-hydroxyethyl]salicylamide monohydrochloride [Substance BNPC]
- Medroxalol [NCIt concept]
- Medroxalol [ICHI extension code]
CISMeF manual mappings
- 5-[2-[[3-(1,3-benzodioxol-5-yl)-1-methylpropyl]amino]-1-hydroxyethyl]salicylamide [Substance BNPC]
Currated CISMeF NLP mapping
- Medroxalol [ICD-11 Extension code]
MeSH term(s) associated for indexing
- ethanolamines [MeSH Descriptor]
Pharmacological action(s)
- adrenergic alpha-antagonists [MeSH Descriptor]
- adrenergic beta-antagonists [MeSH Descriptor]
- antihypertensive agents [MeSH Descriptor]
Record concept(s)
- MDL 17330A [MeSH concept]
- MDL 17331A [MeSH concept]
- RMI 81968 [MeSH concept]
- medroxalol [MeSH concept]
- medroxalol monohydrochloride [MeSH concept]
- medroxalol monohydrochloride, (R-(R*,R*))-isomer [MeSH concept]
- medroxalol monohydrochloride, (R-(R*,S*))-isomer [MeSH concept]
- medroxalol monohydrochloride, (S-(R*,R*))-isomer [MeSH concept]
- medroxalol monohydrochloride, (S-(R*,S*))-isomer [MeSH concept]
See also inter- (CISMeF)
- 5-[2-[[3-(1,3-benzodioxol-5-yl)-1-methylpropyl]amino]-1-hydroxyethyl]salicylamide monohydrochloride [Substance BNPC]
Semantic type(s)
- Organic Chemical [UMLS semantic type]
- Pharmacologic Substance [UMLS semantic type]
UMLS correspondences (same concept)
- 5-[2-[[3-(1,3-benzodioxol-5-yl)-1-methylpropyl]amino]-1-hydroxyethyl]salicylamide [Substance BNPC]
- Medroxalol [ICD-11 Extension code]
- Medroxalol [NCIt concept]

Keyword's position in hierarchy(ies) :

You can consult :

recommendations
documents concerning education
documents for patients